Amelogenesis imperfecta nephrocalcinosis
|
0.780 |
Biomarker
|
disease |
CTD_human |
|
|
|
Juvenile-Onset Still Disease
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.
|
19565504 |
2009 |
Juvenile arthritis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.
|
19565504 |
2009 |
Juvenile psoriatic arthritis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.
|
19565504 |
2009 |
Polyarthritis, Juvenile, Rheumatoid Factor Negative
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.
|
19565504 |
2009 |
Polyarthritis, Juvenile, Rheumatoid Factor Positive
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.
|
19565504 |
2009 |
Amelogenesis Imperfecta
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
We found that these mice developed an enamel phenotype that resembles human AI associated with FAM20A mutations, but did not have apparent dentin defects.
|
31667691 |
2019 |
Amelogenesis Imperfecta
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
It has been recently identified that recessive mutations in the FAM20A gene result in amelogenesis imperfecta (AI)-gingival fibromatosis.
|
29439260 |
2018 |
Amelogenesis Imperfecta
|
0.180 |
Biomarker
|
disease |
BEFREE |
Loss of this insertion due to abnormal mRNA splicing interferes with the structure and function of Fam20A, resulting in AI.
|
28432788 |
2017 |
Amelogenesis Imperfecta
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
Mutations in human FAM20A cause amelogenesis imperfecta, gingival fibromatosis and kidney problems.
|
27281036 |
2016 |
Amelogenesis Imperfecta
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
Novel FAM20A mutation causes autosomal recessive amelogenesis imperfecta.
|
25827751 |
2015 |
Amelogenesis Imperfecta
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
Our finding confirms that the mutations of FAM20A gene are causative for amelogenesis imperfecta and gingival fibromatosis and underlines the recurrent character of the c.34_35delCT in two different ethnic groups.
|
25636655 |
2015 |
Amelogenesis Imperfecta
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
We report on two unrelated Thai patients with three novel and one previously reported mutations in FAM20A with findings suggesting both disorders, including hypoplastic AI, gingival fibromatosis, unerupted teeth, aggressive periodontitis, and nephrocalcinosis/nephrolithiasis.
|
24259279 |
2014 |
Amelogenesis Imperfecta
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
This autosomal recessive disorder, also known as enamel renal syndrome, of FAM20A causes nephrocalcinosis and amelogenesis imperfecta.
|
23434854 |
2012 |
Amelogenesis Imperfecta
|
0.180 |
Biomarker
|
disease |
HPO |
|
|
|
Nephrocalcinosis
|
0.140 |
GeneticVariation
|
disease |
BEFREE |
Recessive FAM20A mutations can cause nephrocalcinosis in addition to the oral phenotype.
|
29439260 |
2018 |
Nephrocalcinosis
|
0.140 |
GeneticVariation
|
disease |
BEFREE |
Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in FAM20A, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic type, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.
|
28298625 |
2017 |
Nephrocalcinosis
|
0.140 |
GeneticVariation
|
disease |
BEFREE |
Greater promotory activity of urine on calcium oxalate crystal growth compared to controls may help to explain the pathogenesis, and suggest that FAM20A mutations can contribute to nephrocalcinosis/nephrolithiasis.
|
24259279 |
2014 |
Nephrocalcinosis
|
0.140 |
GeneticVariation
|
disease |
BEFREE |
We speculate that all individuals with biallelic FAM20A mutations will eventually show nephrocalcinosis.
|
23434854 |
2012 |
Nephrocalcinosis
|
0.140 |
Biomarker
|
disease |
HPO |
|
|
|
Kidney Diseases
|
0.110 |
GeneticVariation
|
group |
BEFREE |
AI patients with similar clinical phenotypes and FAM20A mutations should be examined for nephropathy even if they lack pertinent symptoms.
|
29439260 |
2018 |
Kidney Diseases
|
0.110 |
Biomarker
|
group |
HPO |
|
|
|
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Lymphocyte Count measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
The combination of a genome-wide association study of lymphocyte count and analysis of gene expression data reveals novel asthma candidate genes.
|
22286170 |
2012 |
Enuresis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|